![]() |
![]() | ![]() |
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
Here's one to watch!!! Maxxon, Inc is stepping into a $3 billion dollar market for disposable syringes with their product - the Maxxon Safety Syringe. This company has recently signed a letter of intent to acquire an exclusive worldwide license to manufacture and market a patented disposable syringe with automatic needle retraction. Over 300 healthcare employees die annually from needlestick injuries and Maxxon is poised with their product to solve this problem. Shares outstanding: 8,353,000 Float: 475,000 Share price: 5.25 - 5.50 A contact person is Bill Robinson at 888-492-1257. | ||||||||||||||
|
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |